Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on DC STEM Digest.
Compass Point Expands its Digital Asset Equity Research Coverage
EIN Presswire
·
September 4, 2025
WASHINGTON, DC, UNITED STATES, September 4, 2025 /EINPresswire.com/ -- Compass Point Expands its Digital Asset Equity Research Coverage Compass Point, a leading full-service middle market investment bank, is pleased to announce the expansion of...
BioCardia CEO Peter Altman to Present at the H. C. Wainwright 27th Annual Global Investment Conference in New York City September 8-10, 2025
GlobeNewswire, Inc.
·
September 4, 2025
SUNNYVALE, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- - BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces that BioCardia’s President...
CytoDyn Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire, Inc.
·
September 4, 2025
VANCOUVER, Washington, Sept. 04, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage biotechnology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5...
Kane Biotech to Present revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Fall Conference
GlobeNewswire, Inc.
·
September 4, 2025
WINNIPEG, Manitoba, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces that Interim Chief Executive Officer, Dr. Robert Huizinga, will be presenting at the Symposium on...
BioXcel Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire, Inc.
·
September 4, 2025
NEW HAVEN, Conn., Sept. 04, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that Vimal Mehta,...
GT Biopharma to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire, Inc.
·
September 4, 2025
The Company is available for one-on-one meetings at the H.C. Wainwright Conference September 8-10, 2025 in New York City Phase 1 trial evaluating GTBP-3650 for the treatment of relapsed or refractory (r/r) CD33 expressing hematologic malignancies...
NextCure to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire, Inc.
·
September 4, 2025
BELTSVILLE, Md., Sept. 04, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today...
Zevra Therapeutics Presents Positive New Data Supporting Foundational Role of MIPLYFFA® (arimoclomol) for the Treatment of Niemann-Pick Disease Type C at the International Congress of Inborn Errors of Metabolism (ICIEM)
GlobeNewswire, Inc.
·
September 4, 2025
New data from pre-specified analysis shows patients on concomitant miglustat who switched from placebo to MIPLYFFA experienced a decline in annual disease progression Nomination for Best Poster Award received for poster highlighting MIPLYFFA’s...
NAB Show New York Returns Oct. 22–23 with Top-Tier Speakers, Fresh Programming and Future-focused Trends
GlobeNewswire, Inc.
·
September 4, 2025
Washington, D.C., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Washington, D.C.— The National Association of Broadcasters (NAB) today announced details for the 2025 NAB Show New York, taking place Oct. 22–23 at the Javits Center. Recognized as the East...
What’s Really Going On With Federal Funding? SMI and Travis Taylor Lead iC³® Summit Panel Discussion to Deliver Clarity in a Volatile Policy Era
GlobeNewswire, Inc.
·
September 4, 2025
DALLAS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Institutions, and organizations across the life sciences continuum are seeking clarity on how federal research and development (R&D) funding and critical resources can be secured in the current evolving...
All Talentz, U.S. Chamber of Commerce, and American Business Council Convene Leaders on Advancing Global Business Services Between the U.S. and Nigeria
GlobeNewswire, Inc.
·
September 4, 2025
WASHINGTON, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The American Business Council Nigeria (ABC) and the U.S.-Africa Business Center of the U.S. Chamber of Commerce, in partnership with All Talentz LLC, hosted a high-level dialogue in Washington, D.C....
New Study: Gut Health Program Cuts Infant Eczema Odds by 83% in C-Section Babies
GlobeNewswire, Inc.
·
September 3, 2025
AUSTIN, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) -- A new study found that babies born by C-section had 83% lower odds of developing eczema when their families participated in a 6-month gut health support program, compared to those who didn't...
Opus Genetics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire, Inc.
·
September 3, 2025
RESEARCH TRIANGLE PARK, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (the “Company” or “Opus Genetics”), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal...
The Brookbush Institute Publishes a NEW Glossary Term: 'Observational Research'
EIN Presswire
·
September 3, 2025
The Brookbush Institute continues to enhance education with new courses, a modern glossary, an AI Tutor, and a client program generator. NEW YORK, NY, UNITED STATES, September 3, 2025 /EINPresswire.com/ -- Excerpt from Glossary Term:...
60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire, Inc.
·
September 3, 2025
WASHINGTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne diseases, announced today...
PolyPid to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
GlobeNewswire, Inc.
·
September 3, 2025
PETACH TIKVA, Israel, Sept. 03, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that senior management will participate in the...
Ernexa Therapeutics Announces Presentation At The H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire, Inc.
·
September 3, 2025
CAMBRIDGE, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced it will be featured as a...
NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th
GlobeNewswire, Inc.
·
September 3, 2025
WILMINGTON, Del., Sept. 03, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", or the "Company"), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., ("HOPE," or the "Company"), an...
Celularity Announces Filing of Form 10-Q Quarterly Reports for the First Quarter and the Second Quarter 2025, Confirmation of Nasdaq Listing Rule 5250(c)(1) Compliance
GlobeNewswire, Inc.
·
September 3, 2025
Company on Friday, August 29, 2025, filed quarterly reports on Form 10-Q for the periods ended March 31, 2025, and June 30, 2025, respectively, in accord with its August 11, 2025 updated Nasdaq compliance plan. Company also announces notification...
Beyond Air to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire, Inc.
·
September 3, 2025
GARDEN CITY, N.Y., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve...